Inhibikase Therapeutics (IKT) Prepaid Assets (2020 - 2025)
Historic Prepaid Assets for Inhibikase Therapeutics (IKT) over the last 6 years, with Q3 2025 value amounting to $618783.0.
- Inhibikase Therapeutics' Prepaid Assets rose 12027.49% to $618783.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $618783.0, marking a year-over-year increase of 12027.49%. This contributed to the annual value of $826473.0 for FY2024, which is 1180.96% up from last year.
- Inhibikase Therapeutics' Prepaid Assets amounted to $618783.0 in Q3 2025, which was up 12027.49% from $682628.0 recorded in Q2 2025.
- In the past 5 years, Inhibikase Therapeutics' Prepaid Assets registered a high of $1.5 million during Q4 2021, and its lowest value of $280914.0 during Q3 2024.
- Moreover, its 5-year median value for Prepaid Assets was $851057.0 (2024), whereas its average is $814701.4.
- In the last 5 years, Inhibikase Therapeutics' Prepaid Assets tumbled by 6015.33% in 2023 and then skyrocketed by 12027.49% in 2025.
- Inhibikase Therapeutics' Prepaid Assets (Quarter) stood at $1.5 million in 2021, then fell by 25.63% to $1.1 million in 2022, then tumbled by 33.86% to $739179.0 in 2023, then rose by 11.81% to $826473.0 in 2024, then dropped by 25.13% to $618783.0 in 2025.
- Its Prepaid Assets stands at $618783.0 for Q3 2025, versus $682628.0 for Q2 2025 and $931992.0 for Q1 2025.